⇑ Genmab Stocks Surge Amid Prospective Acquisitions, Strong Quarterly Results, and Analyst Upgrades
Genmab , a leading player in the bio-tech market, has been the focus of significant market attention. Despite some recent drops, such as a 3% drop...
about 1 month ago